IP Library Patent Application 15761899
Patent Application
App. No. 15/761,899

PROTECTED DNA TEMPLATES FOR GENE MODIFICATION AND INCREASED HOMOLOGOUS RECOMBINATION IN CELLS AND METHODS OF USE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/761,899
Abstract

Compositions and methods are provided for modifying a nucleotide sequence in the genome of a cell. The methods and compositions employ a guide polynucleotide, a protected polynucleotide modification template and a Cas endonuclease to modify a nucleotide sequence and/or to increase the frequency of homologous directed repair. The methods can further be used to decrease the frequency of off-site integration of any modification template. The present disclosure also describes methods for selecting a cell comprising a modified target site in its genome and methods for selecting a cell comprising a polynucleotide of interest inserted into a target site in its genome.

Claims (20)

1 . A method for selecting a cell comprising a modified nucleotide sequence in its genome, the method comprising:

a. providing a guide polynucleotide, at least one a protected polynucleotide modification template and a Cas endonuclease to a cell, wherein said Cas endonuclease and guide polynucleotide can form a complex capable of introducing a single or double-strand break at a target site in genome of said cell, wherein said protected polynucleotide modification template comprises at least one nucleotide modification of said nucleotide sequence; and,

b. selecting a cell from step (a) comprising said modified nucleotide sequence.

2 . The method of claim 1 , wherein the protected polynucleotide modification template is a linear polynucleotide comprising at least one protection molecule at its 5′ end, 3′ end, or both 5′ and 3′ ends.

3 . The method of claim 2 , wherein the protection molecule is selected from the group consisting of an alkane spacer, a fluorophore, a NHS ester, a Digoxigen, a Cholesteryl-TEG, a C6, a C12, a Hexynyl, Oxtadiynyl dUTP, a Biotin, a Dithiol, an inverted Dideoxy-T modification or any one combination thereof.

4 . The method of claim 1 , wherein the protected polynucleotide modification template is a circular polynucleotide.

5 . The method of claim 1 , wherein said protected polynucleotide modification template is a double stranded linear molecule comprising at least one phosphorothiate bond at the 5′ end of at least one strand.

6 . The method of claim 1 , wherein said protected polynucleotide modification template is a single stranded linear molecule comprising at least one phosphorothiate bond at its 5′ end.

7 . The method of any one of claims 1 - 6 , wherein the at least one nucleotide modification of the protected polynucleotide template is selected from the group consisting of (i) a replacement of at least one nucleotide, (ii) a deletion of at least one nucleotide, (iii) an insertion of at least one nucleotide, and (iv) any combination of (i)-(iii).

8 . The method of claim 1 , further determining the frequency of Homologous Directed Repair (HDR) and/or Non-Homologous End Joining (NHEJ) in said cell.

9 . The method of claim 8 , wherein the frequency of HDR is increased when compared to the frequency of HDR derived from a control method having all the same components and steps as the method of claim 1 except for using an unprotected (control) polynucleotide modification template.

10 . The method of claim 8 , wherein the frequency of NHEJ is decreased when compared to the frequency of NHEJ derived from a control method having all the same components and steps as the method of claim 1 except for using an unprotected (control) polynucleotide modification template.

11 . The method of claim 1 , further determining the frequency of off-site integration of the protected polynucleotide modification template in said cell.

12 . The method of claim 11 , wherein the frequency of off-site integration of the protected polynucleotide modification template in said cell is decreased when compared to the frequency of off-site integration derived from a control method having all the same components and steps as the method of claim 1 except for using an unprotected (control) polynucleotide modification template.

13 . A method for selecting a microbial cell comprising a polynucleotide of interest inserted into a target site in its genome, the method comprising:

a. providing a guide polynucleotide, at least one protected polynucleotide donor DNA and a Cas endonuclease to a cell, wherein said Cas endonuclease and guide polynucleotide can form a complex capable of introducing a single or double-strand break at a target site in the genome of said cell, wherein said protected polynucleotide donor DNA comprises a polynucleotide of interest to be inserted into the genome of said cell; and,

b. selecting a microbial cell from step (a) comprising a polynucleotide of interest inserted into a target site in its genome.

14 . The method of claim 13 wherein the microbial cell is a non-conventional yeast.

15 . The non-conventional yeast of claim 14 , wherein said yeast is a member of a genus selected from the group consisting of Yarrowia, Pichia, Schwanniomyces, Kluyveromyces, Arxula, Trichosporon, Candida, Ustilago, Torulopsis, Zygosaccharomyces, Trigonopsis, Cryptococcus, Rhodotorula, Phaffia, Sporobolomyces , and Pachysolen.

16 . The method of claim 13 , further comprising producing a plant from the cell of a (b).

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE DESIGNATION OF ASSIGNEE AS A DELAWARE CORPORATION TO A DELAWARE LIMITED LIABILITY COMPANY PREVIOUSLY RECORDED ON REEL 049880 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 051502/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 049880/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2018
From: FRISCH, RYAN L
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 046706/0606 →